X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF UROLOGY

期刊標題檢索 J UROLOGY 最新評論: Is there a submission letter immediately after submitting the document... (2024-08-23)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF UROLOGY]您好,您是該頁面的第 51883 位訪客。

期刊簡介
期刊名稱JOURNAL OF UROLOGY JOURNAL OF UROLOGY
LetPub Score
8.0
51 ratings
Rate

Reputation
8.7

Influence
7.1

Speed
9.4

期刊簡稱J UROLOGY
ISSN0022-5347
E-ISSN1527-3792
h-index236
CiteScore
CiteScoreSJRSNIPCiteScore Rank
11.501.9382.277
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Urology
Q14 / 120

自引率 (2023-2024)6.80%自引率趨勢
掲載範囲
The Official Journal of the American Urological Association (AUA), and the most widely read and highly cited journal in the field, The Journal of Urology® brings solid coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of urology. This premier journal presents investigative studies on critical areas of research and practice, survey articles providing short condensations of the best and most important urology literature worldwide, and practice-oriented reports on significant clinical observations.
官方網站http://www.jurology.com/
在線稿件提交https://www.editorialmanager.com/JU
開放訪問No
出版商Elsevier Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1917
每年文章數203每年文章數趨勢
黃金OA百分比6.11%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
UROLOGY & NEPHROLOGYSCIEQ110/126
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-5347%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Very fast, 2-3 Week(s)
競爭力 *來自作者的數據: Difficult
在線文章發布時間來自Elsevier的數據: Average 14.5 Week(s)
參考鏈接
相關期刊 【JOURNAL OF UROLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews NephrologyH-index: 88

    CiteScore: 39.00
    EUROPEAN UROLOGYH-index: 187

    CiteScore: 43.00
    KIDNEY INTERNATIONALH-index: 250

    CiteScore: 23.30
    Nature Reviews UrologyH-index: 65

    CiteScore: 12.50
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGYH-index: 253

    CiteScore: 22.40
    AMERICAN JOURNAL OF KIDNEY DISEASESH-index: 196

    CiteScore: 20.40
    Clinical Journal of the American Society of NephrologyH-index: 128

    CiteScore: 12.20
    PROSTATE CANCER AND PROSTATIC DISEASESH-index: 56

    CiteScore: 10.00
    NEPHROLOGY DIALYSIS TRANSPLANTATIONH-index: 155

    CiteScore: 10.10
    AMERICAN JOURNAL OF NEPHROLOGYH-index: 75

    CiteScore: 7.50
    學科內最受檢索的期刊 頁面查看次數
    KIDNEY INTERNATIONAL58876
    RENAL FAILURE56162
    BJU INTERNATIONAL49353
    EUROPEAN UROLOGY44654
    INTERNATIONAL UROLOGY AND NEPHROLOGY43151
    UROLOGY42127
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY40565
    ASIAN JOURNAL OF ANDROLOGY39347
    PROSTATE38708
    NEPHROLOGY DIALYSIS TRANSPLANTATION38553
  •  

    JOURNAL OF UROLOGY JOURNAL OF UROLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [JOURNAL OF UROLOGY] 的評論撰寫評論
作者: 终幕乐白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-23 16:05:42 評論於
Is there a submission letter immediately after submitting the document? (*Submission of documents*)
(0) 讚! | 终幕乐白

作者: 坠星晓凡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-30 15:15:18 評論於
It has been 5 days since my application status changed to "Decision in Process", I guess I will probably be rejected...
(0) 讚! | 坠星晓凡

作者: 独孤婉然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-24 20:58:29 評論於
The submission was rejected the next day, with some feedback given. The requirement for originality and the target audience were very high, making it very challenging.
(1) 讚! | 独孤婉然

作者: Nabi2022


領域: 医学
審稿時間: 4.0 month(s)
結果: 拒稿


撰寫評論

2024-02-08 18:42:19 評論於
Submitted by the end of July, the manuscript went through 3 weeks of review with the Editor, and it took 4 months to receive the results of the external review. There were 3 reviewers, with 2 recommending revisions and 1 rejecting the manuscript, ultimately resulting in rejection. Currently, JU has a large number of submissions, causing the review process to be longer, with an average of 3 months for the first review. JU has published a large number of Letters, presumably to maintain its impact factor. As an established journal, it was only categorized as a second-tier journal by the Chinese Academy of Sciences in 2023
(4) 讚! | Nabi2022

作者: 坠星成风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-02 08:38:32 評論於
Excuse me, where did you find the font for this magazine?
(0) 讚! | 坠星成风

作者: Tammy Adelaide


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-06 23:00:57 評論於
Do I need to pay a review fee? Will my submission be rejected after review?
(0) 讚! | Tammy Adelaide

作者: Littlebush


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-01 19:22:13 評論於
The Journal of Urology is unexpectedly only in the 2nd tier of the Chinese Academy of Sciences. CAS is indeed the ultimate truth in the universe.
(1) 讚! | Littlebush

作者: Pamela Nora


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-12 12:11:20 評論於
Does this magazine currently require a layout fee? Is there a section for submissions in the submission system?
(0) 讚! | Pamela Nora

作者: Everley Whitehead


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-02 11:58:53 評論於
Can I submit an article on prostate cancer in molecular biology experiments?
(0) 讚! | Everley Whitehead

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:43:01 評論於
We suggest dividing the discussion of research limitations into three parts: (1) presenting research limitations; (2) explaining research limitations in detail; and (3) suggesting future research directions or improvement plans. By discussing research limitations in this order, you can clearly present the shortcomings of the research without compromising its quality and validity
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:02:57 評論於
It is still necessary to clearly explain the limitations of the research in the paper and to explain how these limitations have affected the conclusions of the paper, so that reviewers and other readers can understand that we have fully considered the limitations of the research. Discussing the limitations of the research work in the discussion section generally makes the article more credible. Thinking about how to overcome these limitations in future research will have a positive effect
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 16:10:43 評論於
Do we need to specify the limitations of the article in the discussion?
(0) 讚! | 八坂篷蔚

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 08:00:21 評論於
How to Write about Limitations in a Discussion?
(0) 讚! | 八坂篷蔚

作者: 清怡可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-01 19:47:28 評論於
Any progress with the editor after 10 days?
(0) 讚! | 清怡可爱吗

作者: 清怡可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-01 18:50:34 評論於
Do you have any progress now?
(0) 讚! | 清怡可爱吗

作者: Leiharlan


領域: 医学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-29 16:25:59 評論於
I have also been with the editor for a month. What is the situation with the original poster?
(0) 讚! | Leiharlan

作者: 璃月安晴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-26 20:20:36 評論於
I'm also wondering, it has been 20 days since my with editor
(0) 讚! | 璃月安晴

作者: 金山访波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-21 23:17:03 評論於
Hello teacher, may I ask if this magazine accepts A case series and literature review? Thank you
(0) 讚! | 金山访波

作者: pxw1237


領域: 医学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-22 09:39:21 評論於
What's going on with editor for one month? I submitted on March 21st, and it's still with editor on April 22nd. Feeling confused.
(0) 讚! | pxw1237

作者: hualala


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2021-03-27 21:42:22 評論於
The manuscript review is fast, with a response given within a month. There are a total of 7 reviewers, some of whom are very meticulous while others only provide comments based on the abstract. Overall, the efficiency is very high and they are very responsible.
(0) 讚! | hualala

作者: Han


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2021-03-12 08:34:01 評論於
2022.03.12 Rejection. Three reviewers, one of whom provided me with 18 suggestions. Thankful! I will make further modifications and then resubmit!
(0) 讚! | Han

作者: Han


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-07 20:38:52 評論於
The text translates to English as:

2021.03.06 Status changed to Required Reviews Completed.
We should know the review results in another week.
Nervous.
If rejected, the next submission will be to BJOG.
(0) 讚! | Han

作者: Han


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-19 21:40:37 評論於
Posted on 2021.02.03, with editor for 2 weeks, sent for external review on 2021.02.16. Currently waiting.
(1) 讚! | Han

作者: Lauren Barnard


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-27 08:17:16 評論於
How are you doing now, dear?
(0) 讚! | Lauren Barnard

作者: 黑山醉巧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-07-21 08:41:20 評論於
How are you doing now?
(0) 讚! | 黑山醉巧

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [JOURNAL OF UROLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*